Digital product labelling: Government pushes forward with national standard, trans-Tasman medicine alignment, and food trial
New Zealand will introduce digital product labelling through a national standard now under development, with the Government forecasting $111 million in economic benefit over ten years.
Regulations Minister David Seymour announced on 6 September 2026 that the national standard will allow real-time updates to product information, lower compliance costs for businesses, and reduce the shelf space taken up by physical labels. RNZ
Seymour was explicit that digital labels would not replace physical labelling outright. Instead, the standard gives businesses the option to adopt the current global standard for digital labelling. The changes stem from a regulatory review of product labelling conducted by the Ministry for Regulation, which has been examining how New Zealand's labelling regime could be modernised. Seymour said decisions on the remainder of the product labelling review have yet to be made. RNZ
A specific trans-Tasman element is embedded in the announcement: over-the-counter medicine labelling in New Zealand will be aligned with Australia's regime, so companies no longer need to produce New Zealand-specific labels. That removes a long-standing compliance cost for pharmaceutical suppliers operating on both sides of the Tasman.
The product labelling review sits alongside a parallel but distinct workstream on digital food labelling, which has been progressing through the Ministry for Primary Industries and New Zealand Food Safety for over a year.
New Zealand Food Safety is planning a one-year trial of digital food labels on selected imported packaged foods, with an Expression-of-Interest process for approved retailers having closed on 8 April 2026. A small number of approved retailers will be temporarily exempt from existing physical labelling requirements under the Australia New Zealand Food Standards Code during the trial period. All other retailers will continue to display normal physical labels. Beehive
The trial is limited to lower-risk, pre-packaged imported foods. Products included will carry physical labels that comply with the rules of countries possessing food regulatory systems comparable to New Zealand's, with all information consumers are accustomed to seeing on labels available digitally. Every product in the trial must comply with the Food Act 2014, the compositional requirements of the Australia New Zealand Food Standards Code, and all other relevant legislation. Beehive
New Zealand Food Safety will assess potential participants, run the trial, provide guidance, and monitor performance throughout. The trial's outcomes will inform broader consideration of digital labelling for food by Food Standards Australia New Zealand. Beehive
The path to the food trial has moved through several stages. Finance Minister Nicola Willis, in her capacity as Economic Growth Minister, and Food Safety Minister Andrew Hoggard announced in November 2025 that consultation had begun on allowing digital labels for lower-risk food products. That consultation was a statutory requirement under the Food Act. The Ministry for Primary Industries had earlier opened a consultation on a limited trial proposal, with submissions closing on 19 December 2025, and published a summary of those submissions in March 2026. OpenGov Asia MPI MPI
The Beehive confirmed in March 2026 that the Government would proceed with the trial following the consultation process. Beehive
The broader context here is one of incremental regulatory convergence across product categories. The Ministry for Regulation's review covers labelling well beyond food, and Seymour's announcement of a national digital standard signals Government intent to create a framework that can apply horizontally rather than through sector-by-sector carve-outs. The trans-Tasman medicine alignment is the clearest expression of that approach: removing country-specific label requirements reduces compliance friction without dismantling the underlying regulatory regime.
For businesses, the practical implications are twofold. Companies that already operate under recognised international standards in jurisdictions with comparable food safety systems may gain a pathway to reduced physical labelling obligations in New Zealand, at least within the trial's scope. Pharmaceutical suppliers stand to benefit more immediately from the OTC medicine alignment, which eliminates the need for a separate New Zealand label run.
For regulators, the food trial functions as a test case. FSANZ will be watching the results to inform its own trans-Tasman position on digital food labelling. The trial's design, which preserves physical labels compliant with comparable jurisdictions and layers digital information on top, is a conservative model that minimises consumer-protection risk while testing whether the digital channel can carry mandatory information reliably.
The $111 million figure attached to the national standard is a ten-year forecast. Whether it materialises will depend on uptake rates, the final scope of the standard, and how many of the review's remaining recommendations the Government adopts. Seymour's framing of digital labelling as optional rather than replacement signals a voluntary regime, at least initially, which tempers expectations of rapid adoption. The sectors most likely to move first are those with the highest labelling compliance costs and the strongest existing digital infrastructure.
What remains undecided is the rest of the product labelling review. Seymour has indicated further decisions are pending, and the Ministry for Regulation's review page continues to list the review as ongoing. The 6 September announcement thus covers one component of a wider reform programme, not its conclusion. RNZ Regulation.govt.nz
